Fischer Medical Ventures Ltd
Incorporated in 1993, Fischer Chemic Ltd does trading of chemicals and machineries[1]
- Market Cap ₹ 2,374 Cr.
- Current Price ₹ 36.2
- High / Low ₹ 125 / 32.0
- Stock P/E 76.5
- Book Value ₹ 5.88
- Dividend Yield 0.01 %
- ROCE 11.4 %
- ROE 8.59 %
- Face Value ₹ 1.00
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 6.16 times its book value
- Company has a low return on equity of 5.54% over last 3 years.
- Company has high debtors of 342 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE 1000
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| 0 | 21 | 111 | 309 | |
| 0 | 19 | 108 | 266 | |
| Operating Profit | 0 | 2 | 3 | 43 |
| OPM % | 11% | 9% | 3% | 14% |
| 0 | 0 | 1 | 12 | |
| Interest | 0 | 0 | 0 | 6 |
| Depreciation | 0 | 0 | 2 | 3 |
| Profit before tax | 0 | 2 | 2 | 47 |
| Tax % | 13% | 45% | 33% | |
| -0 | 2 | 1 | 31 | |
| EPS in Rs | -0.24 | 0.03 | 0.02 | 0.47 |
| Dividend Payout % | 0% | 0% | 22% | 11% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 1097% |
| TTM: | 179% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 820% |
| TTM: | 2010% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 67% |
| 5 Years: | 69% |
| 3 Years: | 45% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| Last Year: | 9% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 0.17 | 54 | 64 | 65 |
| Reserves | -0 | 28 | 274 | 319 |
| 1 | 2 | 85 | 107 | |
| 0 | 4 | 34 | 180 | |
| Total Liabilities | 0 | 86 | 457 | 672 |
| 0 | 15 | 24 | 33 | |
| CWIP | 0 | 0 | 1 | 3 |
| Investments | 0 | 1 | 11 | 123 |
| 0 | 70 | 421 | 513 | |
| Total Assets | 0 | 86 | 457 | 672 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| -7 | -87 | |||
| -29 | -125 | |||
| 37 | 315 | |||
| Net Cash Flow | 1 | 103 | ||
| Free Cash Flow | -8 | -93 | ||
| CFO/OP | -392% | -3,001% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor Days | 345 | 398 | 251 | 342 |
| Inventory Days | 99 | 36 | 32 | |
| Days Payable | 48 | 82 | 263 | |
| Cash Conversion Cycle | 345 | 449 | 205 | 111 |
| Working Capital Days | 324 | 498 | 40 | 155 |
| ROCE % | 5% | 1% | 11% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Consultancy & AMC INR Lakhs ・Standalone data |
|
||||||||||
| Number of Permanent Employees Number ・Standalone data |
|||||||||||
| Health Screenings Conducted Number |
|||||||||||
| Target Educational Distribution (TAG Schools) Number of Schools |
|||||||||||
Extracted by Screener AI
Documents
Announcements
- Financial Results For The Quarter And Year Ended 31.03.2026 20h
-
Board Meeting Outcome for Oucome Of BM
2d - Board approved audited FY26 results, recommended Rs0.05 dividend, and appointed internal auditors.
-
Finanacial Results
2d - Board approved FY26 audited results, appointed internal auditors, and recommended Rs0.05 final dividend per share.
-
Corporate Action-Board approves Dividend
2d - Board recommended 5% final dividend of Re. 0.05 per share for FY 2025-26.
-
Board Meeting Intimation for Audit Financial Results Q4 And FY Ending 31St March 2026
25 May - Board meeting on 29 May 2026 to approve audited FY26 results and consider dividend.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Nov 2025Transcript PPT
-
Dec 2024TranscriptAI SummaryPPT
Business Overview:[1]
Company is in the business of processing, manufacturing and trading of Laboratory Grade Chemicals